Summary: While psychedelic research often focuses on hours-long “trips” with psilocybin or LSD, a landmark Phase IIa trial has proven that a much shorter experience can be just as potent. Using DMT, the primary psychoactive compound in…
Continue Reading
News Source: neurosciencenews.com

Leave a Reply